AHA to Sen. Leahy Re: the CREATES Act of 2017

AHa letter to Sen. Leahy regarding the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2017.

Key Resources

Related Resources

Advisory
Trump Administration Issues Order on Drug Pricing
Member
AHA Center for Health Innovation Market Scan
RFID Solutions Attract Attention for Medication Inventory Management
Public
Letter/Comment
AHA Urges Administration to Grant Exceptions for Tariffs for Medications and Medical Supplies
Public
Fact Sheets
Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements
Public
Letter/Comment
AHA Comments on CMS Proposed Medicare Drug Pricing Model
Public
Advisory
CMS Finalizes Guidance on Implementation of the Medicare Drug Price Negotiation Program
Member